Benjamin, Daniel I <br/><br/>
Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells.  [electronic resource] 

 -  ACS chemical biology  Jul 2015 
 - 1616-23 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1554-8937 
<br/><br/><label>Standard No.: </label>10.1021/acschembio.5b00240  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Diglycerides--metabolism<br/>Drug Resistance, Neoplasm<br/>Enzyme Inhibitors--pharmacology<br/>Fatty Acid Synthases--antagonists & inhibitors<br/>Glucose--metabolism<br/>Humans<br/>Neoplasms--drug therapy<br/>Protein Kinase C--metabolism<br/>Signal Transduction--drug effects